Increased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF

Translational Psychiatry

Volumn 5, Issue 11, 2015, Pages

  Buttenschon H N ^a,b   Demontis, D ^a,b   Kaas, M ^a   Elfving, B ^a   Molgaard S ^a   Gustafsen, C ^a   Kaerlev, L ^c,d   Petersen, C M ^a   Borglum A D ^a,b   Mors, O ^b,e   Glerup, S ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b Lundbeck Foundation Initiative for Integrative Psychiatric Research   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE; SORTILIN; VASCULOTROPIN; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; VASCULOTROPIN A; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HIPPOCAMPUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SORTILIN 1 GENE; ANIMAL; BLOOD; C57BL MOUSE; GENETICS;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVEYS AND QUESTIONNAIRES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84979098386     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.167     Document Type: Article

References (44)

1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study. Lancet 2010; 380: 2197-2223.
2. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 2000; 157: 1552-1562.
3. Domenici E. Peripheral biomarkers for depression by plasma and serum proteomics. Adv Biol Psychiatry 2014; 29: 81-91.
4. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148.
5. Glerup S, Nykjaer A, Vaegter CB. Sortilins in neurotrophic factor signaling. Handb Exp Pharmacol 2014; 220: 165-189.
6. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013; 45: 1452-1458.
7. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B et al. A genomewide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13: 197-207.
8. Ollila HM, Soronen P, Silander K, Palo OM, Kieseppa T, Kaunisto MA et al. Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort. Mol Psychiatry 2009; 14: 351-353.
9. Alemany S, Ribases M, Vilor-Tejedor N, Bustamante M, Sánchez-Mora C, Bosch R et al. New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2015 (e-pub ahead of print).
10. Quistgaard EM, Madsen P, Groftehauge MK, Nissen P, Petersen CM, Thirup SS. Ligands bind to sortilin in the tunnel of a ten-bladed beta-propeller domain. Nat Struct Mol Biol 2009; 16: 96-98.
11. Petersen CM, Nielsen MS, Nykjaer A, Jacobsen L, Tommerup N, Rasmussen HH et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem 1997; 272: 3599-3605.
12. Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 2005; 25: 5455-5463.
13. Evans SF, Irmady K, Ostrow K, Kim T, Nykjaer A, Saftig P et al. Neuronal brainderived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation. J Biol Chem 2011; 286: 29556-29567.
14. Vaegter CB, Jansen P, Fjorback AW, Glerup S, Skeldal S, Kjolby M et al. Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. Nat Neurosci 2011; 14: 54-61.
15. Hermey G, Sjogaard SS, Petersen CM, Nykjaer A, Gliemann J. Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10pdomain receptor family members. Biochem J 2006; 395: 285-293.
16. Navarro V, Vincent JP, Mazella J. Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line. Biochem Biophys Res Commun 2002; 298: 760-764.
17. Wilson CM, Naves T, Vincent F, Melloni B, Bonnaud F, Lalloue F et al. Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors. J Cell Sci 2014; 127: 3983-3997.
18. Gustafsen C, Kjolby M, Nyegaard M, Mattheisen M, Lundhede J, Buttenschon H et al. The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion. Cell Metab 2014; 19: 310-318.
19. Zhou L, Xiong J, Lim Y, Ruan Y, Huang C, Zhu Y et al. Upregulation of blood proBDNF and its receptors in major depression. J Affect Disord 2013; 150: 776-784.
20. Harris LW, Pietsch S, Cheng TM, Schwarz E, Guest PC, Bahn S. Comparison of peripheral and central schizophrenia biomarker profiles. PLoS One 2012; 7: E46368.
21. Clark-Raymond A, Halaris A. VEGF and depression: A comprehensive assessment of clinical data. J Psychiatr Res 2013; 47: 1080-1087.
22. Kolstad HA, Hansen AM, Kaergaard A, Thomsen JF, Kaerlev L, Mikkelsen S et al. Job strain and the risk of depression: Is reporting biased? Am J Epidemiol 2011; 173: 94-102.
23. Kaerlev L, Kolstad HA, Hansen AM, Thomsen JF, Kaergaard A, Rugulies R et al. Are risk estimates biased in follow-up studies of psychosocial factors with low baseline participation? BMC Public Health 2011; 11: 539.
24. Wing JK, Sartorius N, Üstün TB. World Health Organization. Diagnosis and clinical measurement in psychiatry. A reference manual for SCAN, 1998.
25. Elfving B, Buttenschon HN, Foldager L, Poulsen PH, Andersen JH, Grynderup MB et al. Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level. J Psychiatr Res 2012; 46: 1118-1125.
26. Elfving B, Buttenschon HN, Foldager L, Poulsen PH, Grynderup MB, Hansen AM et al. Depression and BMI influences the serum vascular endothelial growth factor level. Int J Neuropsychopharmacol 2014; 17: 1409-1417.
27. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53: 441-449.
28. Brugha TS, Cragg D. The List of Threatening Experiences: The reliability and validity of a brief life events questionnaire. Acta Psychiatr Scand 1990; 82: 77-81.
29. Brugha T, Bebbington P, Tennant C, Hurry J. The List of Threatening Experiences: A subset of 12 life event categories with considerable long-term contextual threat. Psychol Med 1985; 15: 189-194.
30. World Health Organization. Geneva (1993) The ICD10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research.
31. Munck Petersen C, Nielsen MS, Jacobsen C, Tauris J, Jacobsen L, Gliemann J et al. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding. EMBO J 1999; 18: 595-604.
32. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
33. Di Lieto A, Rantamäki T, Vesa L, Yanpallewar S, Antila H, Lindholm J et al. The responsiveness of TrkB to BDNF and antidepressant drugs is differentially regulated during mouse development. PLoS One 2012; 7: 3.
34. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
35. Bi L, Chiang JY, Ding WX, Dunn W, Roberts B, Li T. Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J Lipid Res 2013; 54: 2754-2762.
36. Li J, Bi L, Hulke M, Li T. Fish oil and fenofibrate prevented phosphorylationdependent hepatic sortilin 1 degradation in Western diet-fed mice. J Biol Chem 2014; 289: 22437-22449.
37. Di Loreto S, Falone S, D'Alessandro A, Santini S, Sebastiani P, Cacchio M et al. Regular and moderate exercise initiated in middle age prevents age-related amyloidogenesis and preserves synaptic and neuroprotective signaling in mouse brain cortex. Exp Gerontol 2014; 57: 57-65.
38. Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E et al. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients. Eur Neuropsychopharmacol 2013; 23: 1199-1207.
39. Bus BA, Molendijk ML, Penninx BJ, Buitelaar JK, Kenis G, Prickaerts J et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011; 36: 228-239.
40. Davis MI. Ethanol-BDNF interactions: Still more questions than answers. Pharmacol Ther 2008; 118: 36-57.
41. Goldstein BI, Diamantouros A, Schaffer A, Naranjo CA. Pharmacotherapy of alcoholism in patients with co-morbid psychiatric disorders. Drugs 2006; 66: 1229-1237.
42. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 497-511.
43. Kohen R, Kirov S, Navaja GP, Happe HK, Hamblin MW, Snoddy JR et al. Gene expression profiling in the hippocampus of learned helpless and nonhelpless rats. Pharmacogenomics J 2005; 5: 278-291.
44. Prudencio M, Jansen-West KR, Lee WC, Gendron TF, Zhang YJ, Xu YF et al. Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor. Proc Natl Acad Sci USA 2012; 109: 21510-21515.